(3R,4R)-3,4-二甲基-4-(3-羟基苯基)哌啶(119193-19-0)名称与标识符
名称
中文别名:
(3R,4R)-3,4-二甲基-4-(3-羟基苯基)哌啶;3-((3R,4R)-3,4-二甲基哌啶-4-基)苯酚;(3R,4R)-3-(3,4-二甲基-4-哌啶基)苯酚;(+)-(3R,4R)-3,4-二甲基-4-(3-羟基苯基)哌啶;((3R,4R)-3,4-二甲基-4-(3-羟基苯基)哌啶;(+)-(3R,4R)-3,4-二甲基-4-(3-羟苯基)哌啶;2-(4-三氟甲氧基苯基)乙胺;阿维莫泮中间体;爱维莫潘 Alvimopan 片段;爱维莫潘 主环;爱维莫潘中间体;(3R,4R)-3,4-二甲基-4-(3-羟基苯基);(3R,4R)-3-(3,4-二甲基-4-呱啶基)苯酚;(3R,4R)-3,4-二甲基-4-(3-羟苯基)哌啶;(3R,4R)-3,4-二甲基-4-(3-羟基苯基)哌啶; 阿维莫泮中间体;(3R,4R)-3,4-二甲基-4-(3-;(3R,4R)-3,4-二甲基-4-(3-羟基苯基)哌啶 阿维莫泮中间体;
英文别名:
(+)-(3R,4R)-3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE;3-(3,4-diMethylpiperidin-4-yl)phenol;3-[(3R,4R)-3,4-Dimethylpiperidin-4-yl]phenol;(3R,4R)-3-(3,4-Dimethyl-4-piperidinyl)phenol;Phenol,3-[(3R,4R)-3,4-dimethyl-4-piperidinyl]-;3-((3R,4R)-3,4-DIMETHYLPIPERDIN-4-YL)PHENOL;(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine;Alvimopan Intermediate 1;(3R,4R)-3-(3,4-diMethyl-4-piperidiny) phenol;3-((3R,4R)-3,4-diMethylpiperidin-4-yl)phenol;3-[(3R,4R)-3,4-DiMethyl-4-piperidinyl]phenol;(3R-cis)-3-(3,4-diMethyl-4-
piperidinyl)phenol;(+)-(3R,4R)-DiMethyl-4-(3-hydroxyphenyl)piperidine;(+)-4(R)-(3-hydroxyphenyl)-3(R),4-diMethyl-1-piperidine;PHENOL, 3-[(3R,4R)-3,4-DIMETHYL-4-PIPERIDINYL]-;3-[(3R,4R)-3,4-dimethyl-4-piperidyl]phenol;KSC511C2F;HXZDAOSDNCHKFE-GXFFZTMASA-N;3-[(3R,4R)-3,4-Dimethyl-4-piperidinyl]phenol; (3R-cis)-3-(3,4-dimethyl-4-piperidinyl)phenol; (+)-(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine; (+)-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)piperidine;;119193-19-0;SCHEMBL1477254;CS-M1917;AKOS016015268;BCP12721;AKOS015901845;(3R pound not4R)-3 pound not4-Dimethyl-4-(3-hydroxyphenyl)piperidine;MFCD06659960;DTXSID30453444;AS-37611;D5558;
标识符
InChIKey:
HXZDAOSDNCHKFE-GXFFZTMASA-N
Inchi:
1S/C13H19NO/c1-10-9-14-7-6-13(10,2)11-4-3-5-12(15)8-11/h3-5,8,10,14-15H,6-7,9H2,1-2H3/t10-,13+/m0/s1
SMILES:
O([H])C1=C([H])C([H])=C([H])C(=C1[H])[C@]1(C([H])([H])[H])C([H])([H])C([H])([H])N([H])C([H])([H])[C@]1([H])C([H])([H])[H]